Online First

CASE REPORT The oncogenic effect of hepatitis C lasts beyond the disease's eradication Sofia Cerqueira, Catarina Teixeira, Nuno Afonso, Rui Castro, Teresa Morgado, Professor Rui Alves
Hepatitis C virus (HCV) is widely prevalent worldwide, with an estimated 180 million people infected. Its manifestations are not limited to hepatic disease, as it has widely known immunomodulator and oncogenic effects.
Port J Nephrol Hypert 2019; 33(3): 143-144 Advance Access publication 5 September 2019 DOWNLOAD PDF
PERSPECTIVE Pancreas allocation and diabetic end-stage kidney disease Nuno Moreira Fonseca
Transplant options for patients with type 1 diabetes and end-stage kidney disease include deceased donor kidney, live donor kidney, simultaneous pancreas-kidney, pancreas after kidney and islet cell transplantation.
Port J Nephrol Hypert 2019; 33(1): 83-85 Advance Access publication 2 April 2019 DOWNLOAD PDF
CASE REPORT Severe passenger lymphocyte syndrome associated to Rh antibodies after donor living renal transplantation Marika Bini Antunes, Jorge Malheiro, Leonidio Dias, La Salete Martins, Sofia Pedroso, Manuela Almeida, António Castro Henriques, Margarida Amil
The passenger lymphocyte syndrome may cause hemolytic anemia after bone marrow and solid organ transplantation when there is minor erythrocyte antigen incompatibility in the donor/recipient pair.
Port J Nephrol Hypert 2019; 33(2): 83-85 Advance Access publication 8 May 2019 DOWNLOAD PDF
ORIGINAL ARTICLE Kidney dysfunction in renal amyloidosis: does the complement system play a part in hereditary ATTRV30M and iatrogenic ATTR amyloidosis? Ana Carina Ferreira, Fernanda Carvalho, Ana Rita Santos, Fernando Nolasco
Introduction and aims: The complement system may play a part in the pathogenesis of amyloid disorders.
Port J Nephrol Hypert 2019; 33(2): 89-94 Advance Access publication 28 May 2019 DOWNLOAD PDF
REVIEW ARTICLE Treatment options for type 2 diabetes mellitus in patientswith chronic kidney disease - old and new drugs Ana Ferreira, Filipa Bastos, Maria Carlos Cordeiro, Jorge Portugal
Chronic kidney disease is highly prevalent in patients with diabetes mellitus.
Port J Nephrol Hypert 2019; 33(2): 99-107 Advance Access publication 6 June 2019 DOWNLOAD PDF
CASE REPORT Nephronophthisis, a pediatric challenge Ana M. Garcia, Sónia M. Gomes, Telma Francisco, Ana P. Serrão
Nephronophthisis is an autosomal recessive cystic kidney disease characterized by reduced concentrating ability of the kidney, chronic tubulointerstitial nephritis, cystic renal disease and progression to end-stage renal disease.
Port J Nephrol Hypert 2019; 33(2): 109-112 Advance Access publication 26 June 2019 DOWNLOAD PDF
REVIEW ARTICLE Cardiovascular primary prevention - directed approach for individual features Tânia Branco Mano, Sílvia Aguiar Rosa, Pedro Rio, Ana Teresa Timóteo, Rui Cruz Ferreira
Cardiovascular diseases (CVD) remain the leading cause of morbimortality globally.
Port J Nephrol Hypert 2019; 33(2): 119-126 Advance Access publication 27 June 2019 DOWNLOAD PDF
TUBULAR QUIZ Hypokalemia in the setting of acute kidney injury and non-anion gap metabolic acidosis Nuno Moreira Fonseca, Patrícia Alves, David Navarro, João Sousa, Fernando Nolasco
We present a case of a 48-year-old female with past medical history of well-controlled hypertension who was diagnosed with Ewinglike sarcoma, with abdominal wall involvement and pulmonary metastatic lesions.
Port J Nephrol Hypert 2019; 33(2): 139-141 Advance Access publication 4 July 2019 DOWNLOAD PDF
PERSPECTIVE Vascular access for dialysis - the Portuguese experience Carlos Oliveira
Vascular access quality for chronic hemodialysis is a determinant factor in the success of this treatment.
Port J Nephrol Hypert 2019; 33(2): 137-138 Advance Access publication 4 July 2019 DOWNLOAD PDF
COMMENT IgA immune complex deposits, what can lie behind them? Comments on a case of IgA dominant glomerulonephritis associated to staphylococcus infection. Fernanda Carvalho
In this journal Nicole Pestana et al. describe a case of “IgA dominant glomerulonephritis associated to staphylococcus infection”.
Port J Nephrol Hypert 2019; 33(2): 131 Advance Access publication 1 July 2019 DOWNLOAD PDF
PERSPECTIVE Nephrology and intervention in the community ? On the need for improving the interplay between nephrology centers and primary care in Portugal Idalina Beirão, Edgar Almeida
Chronic kidney disease is increasing in prevalence, especially among older people.
Port J Nephrol Hypert 2019; 33(2): 113-114 Advance Access publication 26 June 2019 DOWNLOAD PDF
REVIEW ARTICLE Vitamin D - New insights into an old molecule Cristina Jorge
New data on vitamin D has emerged in the last fifteen years and continues to expand practically every day.
Port J Nephrol Hypert 2019; 33(3): 145-152 Advance Access publication 23 September 2019 DOWNLOAD PDF
REVIEW ARTICLE Contrast agents in Nephrology - a literature review Sara Cardoso Fernandes, Ana Carina Ferreira
Contrast agents are widely used in ambulatory and hospitalized patients, as a complement to imaging studies, improving diagnostic accuracy.
Port J Nephrol Hypert 2019; 33(3): 153-157 Advance Access publication 23 September 2019 DOWNLOAD PDF
REVIEW ARTICLE Comprehensive geriatric assessment in nephrology Ana Farinha, Sofia Duque
In Portugal, in 2018, 64.5% of dialysis patients were elderly and nearly a quarter were older than 80 years.
Port J Nephrol Hypert 2019; 33(3): 159-166 Advance Access publication 27 September 2019 DOWNLOAD PDF
HOT TOPICS IN MEDICINE Carbapenem resistant Enterobacteriaceae - the basics for everymedical specialty Marisa Araújo, Carla Mimoso Santos, Daniela Lages
Enterobacteriaceae are ubiquitous gram‑negative bacilli, part of the intestinal flora.
Port J Nephrol Hypert 2019; 33(3): 167-172 Advance Access publication 1 October 2019 DOWNLOAD PDF
PERSPECTIVE Hocus POCUS in Nephrology: is it time for magic? Hugo Diniz, Luís Coentrão
Point‑of‑care ultrasound (POCUS) is an emerging bedside discipline that aims to enhance physical examination findings with real‑time information from the ultrasound.
Port J Nephrol Hypert 2019; 33(3): 183-184 Advance Access publication 8 October 2019 DOWNLOAD PDF
PERSPECTIVE Planning ESKD treatment: a plea for a stepwise person-centered approach including conservative care Helena Sá, Raymond Vanholder
A paradigm shift in the treatment of end-stage kidney disease (ESKD) is urgently needed.
Port J Nephrol Hypert 2019; 33(3): 177-182 Advance Access publication 8 October 2019 DOWNLOAD PDF
CASE REPORT Fanconi syndrome related to zoledronic acid Margarida Oliveira, M. Teresa Santos, Ana Costa
Fanconi syndrome is characterized by proximal tubular dysfunction, with inability to reabsorb bicarbonate causing type 2 renal tubular acidosis associated with aminoaciduria, normoglycemic glycosuria, hypophosphatemia with phosphaturia and proteinuria.
Port J Nephrol Hypert 2019; 33(3): 185-188 Advance Access publication xx October 2019 DOWNLOAD PDF
ORIGINAL ARTICLE What water should I drink, Doc? Rui F. Silva, Ana Beco, Sofia Marques
Chronic kidney disease (CKD) is commonly associated with normal anion gap metabolic acidosis and its correction has shown multiple benefits, such as improved bone health and nutritional status, a slower progression of CKD and a lower incidence of end-stage renal disease.
Port J Nephrol Hypert 2019; 33(3): 173-176 Advance Access publication 8 October 2019 DOWNLOAD PDF
NEPHROPATHOLOGY QUIZ Pathology turned its back on semiology Sara Barreto, Ana Domingos, David Navarro, Mário Góis, Helena Sousa, Fernando Nolasco
We present a case of a 32‑year‑old caucasian female with systemic lupus erythematosus (SLE) diagnosed 7 years ago.
Port J Nephrol Hypert 2019; 33(2): 189-192 Advance Access publication 2 October 2019 DOWNLOAD PDF
TUBULAR QUIZ Silent hypokalemia - a sometimes fatal condition Carolina Cadório, André Simões, João Gonçalves Pereira
A 69‑year‑old Caucasian female was sent to the emergency room by her general practitioner due to severe hypokalemia (1.7 mmol/L) detected in a routine evaluation.
Port J Nephrol Hypert 2019; 33(2): 193-196 Advance Access publication 7 October 2019 DOWNLOAD PDF
REVIEW ARTICLE Membranous nephropathy: an update Hernando Trujillo, Manuel Praga
Great advances have been made in the pathophysiologic and therapeutic areas of membranous nephropathy in the last years.
Port J Nephrol Hypert 2019; 33(1): 10-18 Advance Access publication 18 February 2019 DOWNLOAD PDF
Patrocinadores            
             
Platina            

           
Ouro            

         
Prata            

 
Bronze            

       
Media Partner